arBtrage CAPITALIZING MARKETS checking… Sign in

Oruka Therapeutics, Inc.

ORKA Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances
$60.14
▼ -3.4% Today
as of Jun 7, 07:23 ET
Last 30 days -18.72% Apr 28 → Jun 05
$53.49 $59.00 $64.50 $70.00 $75.51 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$63.04
High
$63.92
Low
$59.30
Volume
$1M
Avg Vol
$677,938
Mkt Cap
$3.5B
P/E (TTM)
Beta
52w High
$91.00
52w Low
$10.77
Div Yield
Shares Out
$50M

Overview

52-week range
$11
$91
62% of range
Avg surprise (last 2)
+18.8%
Avg reaction (last 2)
-0.7%
50% positive
Latest IV / EM
76%
EM ±10.5% · $60 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-6.96$-5.25$-3.53$-1.81$-0.10 Actual $-0.10Actual $-0.14Actual $-6.96Actual $-1.46Actual $-0.40Est $-0.57Actual $-0.46Actual $-0.48Est $-0.52 SepMarJunSepMar/2025JunMar/2026
Revenue vs Net Income Revenue Net income
$-32M$-29M$-27M$-24M$-22M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.48 $-0.52 +7.7% -20.0% -2.3% earnings
Mon Jun 30, 2025Jun 2025 $-0.46 financials
Wed May 14, 2025Mar/2025 $-0.40 $-0.57 +29.8% +0.9% earnings
Mon Sep 30, 2024Sep 2024 $-1.46 financials
Sun Jun 30, 2024Jun 2024 $-6.96 financials
Sun Mar 31, 2024Mar 2024 $-0.14 financials
Sat Sep 30, 2023Sep 2023 $-0.10 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-36M$-34M$-28M$-25M$-29M$-21M
Net income$-32M$-30M$-25M$-21M$-29M$-22M
EPS (diluted)$-0.46$-0.40$-1.46$-6.96

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$50M$47M$91M$65M$84M$62M$411M$33M
Inventory
Total current assets$395M$344M$355M$332M$352M$377M$413M$34M
Total assets$504M$489M$509M$357M$377M$396M$414M$34M
Long-term debt
Total liabilities$18M$17M$22M$14M$12M$14M$19M$1M
Total equity$487M$472M$487M$344M$365M$382M$342M$-29M

Implied volatility — last 90 days

70%73%75%78%80% Jun 07 — IV 76% · EM ±10.5%

Sector peers